Search - tctmd.com

Displaying 861 - 880 of 1665

Sort: Relevancy | Date

Presentation TCT 2017

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye

October 31, 2017

Presentation TCT 2017

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used Selectively!

Presenter: Michael Mooney, Holger Thiele, Jose P.S. Henriques

October 31, 2017

Presentation TCT 2017

Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs

Presenter: David E. Kandzari, Jaime Raben, John C Laschinger

October 31, 2017

Presentation TCT 2017

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma

October 31, 2017

Presentation TCT 2017

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used in All Patients!

Presenter: Michael Mooney, Holger Thiele, Tanveer Rab

October 31, 2017

Presentation TCT 2017

Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned

Presenter: David E. Kandzari, Jaime Raben

October 31, 2017

Presentation TCT 2017

Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry

Presenter: Michael Mooney, Holger Thiele, Brian P O'Neill

October 31, 2017

Presentation TCT 2017

Mechanical Hemodynamic Support: Counterpulsation, Rotary Flow, or ECMO for Cardiogenic Shock, and Why?

Presenter: Michael Mooney, Holger Thiele, Navin K. Kapur

October 31, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples)

Presenter: David Hildick-Smith, Jeffrey W. Moses, Carlo Briguori

October 31, 2017

Presentation TCT 2017

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra

October 31, 2017

Presentation TCT 2017

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne

October 31, 2017

Presentation TCT 2017

Cardiac Catheterization, Mechanical Support, and Hypothermia in Patients With Cardiac Arrest: State-of-the-Art

Presenter: Michael Mooney, Holger Thiele, Sandeep Nathan

October 31, 2017

Presentation TCT 2017

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Qi Zhang

October 31, 2017

Presentation TCT 2017

The Potential For BRS: What Weve Learned From Pushing The Envelope

Presenter: Stephen G. Ellis, Takeshi Kimura, Corrado Tamburino

October 31, 2017

Presentation TCT 2017

Should the Approach to Multivessel Disease Differ in Patients With and Without Cardiogenic Shock?

Presenter: Michael Mooney, Holger Thiele

October 31, 2017

Presentation TCT 2017

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB SCAAR

Presenter: Stephen G. Ellis, Takeshi Kimura, Stefan K. James

October 31, 2017

Presentation TCT 2017

Hub and Spoke Transfer Strategies in Cardiogenic Shock and Cardiac Arrest: Any Benefit on Outcome?

Presenter: Michael Mooney, Holger Thiele, Christopher B. Granger

October 31, 2017

Presentation TCT 2017

Registry Update: BVS STEMI STRATEGY

Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi

October 31, 2017

Presentation TCT 2017

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Luca Testa

October 31, 2017

Advertisement

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used Selectively!

Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used in All Patients!

Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned

Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry

Mechanical Hemodynamic Support: Counterpulsation, Rotary Flow, or ECMO for Cardiogenic Shock, and Why?

Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples)

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome

Cardiac Catheterization, Mechanical Support, and Hypothermia in Patients With Cardiac Arrest: State-of-the-Art

Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update

The Potential For BRS: What Weve Learned From Pushing The Envelope

Should the Approach to Multivessel Disease Differ in Patients With and Without Cardiogenic Shock?

Buma Stent: Device Specifications, Clinical Trial Results, and Global Development

Registry Update: ABSORB SCAAR

Hub and Spoke Transfer Strategies in Cardiogenic Shock and Cardiac Arrest: Any Benefit on Outcome?

Registry Update: BVS STEMI STRATEGY

Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content